Mark Hassall

1.5k total citations
54 papers, 522 citations indexed

About

Mark Hassall is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mark Hassall has authored 54 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Ophthalmology, 12 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Molecular Biology. Recurrent topics in Mark Hassall's work include Glaucoma and retinal disorders (12 papers), Retinal Diseases and Treatments (9 papers) and Ancient Mediterranean Archaeology and History (6 papers). Mark Hassall is often cited by papers focused on Glaucoma and retinal disorders (12 papers), Retinal Diseases and Treatments (9 papers) and Ancient Mediterranean Archaeology and History (6 papers). Mark Hassall collaborates with scholars based in Australia, United Kingdom and United States. Mark Hassall's co-authors include Jamie E. Craig, Ian Hodder, Ayub Qassim, Robert E. MacLaren, Alun R. Barnard, Mona S. Awadalla, Giada Mattiuzzo, John Landers, Piran C. L. White and Owen M. Siggs and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Mark Hassall

50 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Hassall Australia 15 186 145 88 65 51 54 522
Katarzyna Skonieczna Poland 12 106 0.6× 62 0.4× 131 1.5× 13 0.2× 27 0.5× 28 454
Mirna Kirin United Kingdom 6 74 0.4× 77 0.5× 79 0.9× 26 0.4× 24 0.5× 7 541
Benjamin Chaon United States 7 108 0.6× 33 0.2× 118 1.3× 19 0.3× 30 0.6× 17 346
Debra L. Fisk United States 8 46 0.2× 24 0.2× 75 0.9× 35 0.5× 38 0.7× 11 324
Steve Rabson United States 10 14 0.1× 27 0.2× 78 0.9× 17 0.3× 48 0.9× 43 425
William Beggs United States 11 10 0.1× 16 0.1× 296 3.4× 26 0.4× 43 0.8× 18 823
Kimberly J. Perry United States 18 27 0.1× 147 1.0× 501 5.7× 41 0.6× 169 3.3× 36 1.1k
Hiroyoshi NINOMIYA Japan 13 89 0.5× 64 0.4× 82 0.9× 27 0.4× 15 0.3× 55 369
Stanley J. Cevario United States 13 248 1.3× 36 0.2× 248 2.8× 5 0.1× 68 1.3× 22 668
B A Noble United Kingdom 17 556 3.0× 646 4.5× 80 0.9× 15 0.2× 127 2.5× 39 1.1k

Countries citing papers authored by Mark Hassall

Since Specialization
Citations

This map shows the geographic impact of Mark Hassall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hassall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hassall more than expected).

Fields of papers citing papers by Mark Hassall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hassall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hassall. The network helps show where Mark Hassall may publish in the future.

Co-authorship network of co-authors of Mark Hassall

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hassall. A scholar is included among the top collaborators of Mark Hassall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hassall. Mark Hassall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Jeremy, Hamish Dunn, Anna Galanopoulos, et al.. (2025). Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent. Ophthalmology Glaucoma. 8(4). 367–374. 3 indexed citations
2.
Hassall, Mark, et al.. (2025). Development and evaluation of patient-centred polygenic risk score reports for glaucoma screening. BMC Medical Genomics. 18(1). 21–21.
3.
Keane, Miriam C., et al.. (2024). Healthcare professionals' knowledge and attitudes towards polygenic risk testing for glaucoma. Clinical and Experimental Ophthalmology. 52(9). 957–972. 4 indexed citations
4.
Hassall, Mark, Shari Javadiyan, Sonja Klebe, et al.. (2023). Phenotypic consequences of a nanophthalmos-associated TMEM98 variant in human and mouse. Scientific Reports. 13(1). 11017–11017. 2 indexed citations
5.
Grehan, Keith, Mark Hassall, Guido C. Paesen, et al.. (2023). VelcroVax: a “Bolt-On” Vaccine Platform for Glycoprotein Display. mSphere. 8(1). e0056822–e0056822. 3 indexed citations
6.
Souzeau, Emmanuelle, Owen M. Siggs, Sean Mullany, et al.. (2022). Diagnostic yield of candidate genes in an Australian corneal dystrophy cohort. Molecular Genetics & Genomic Medicine. 10(10). e2023–e2023. 4 indexed citations
7.
Stretton, Brandon, et al.. (2022). The Role of Tocilizumab in Glucocorticoid Resistant Giant Cell Arteritis: A Case Series and Literature Review. Journal of Neuro-Ophthalmology. 43(1). 91–95. 6 indexed citations
8.
Hassall, Mark, et al.. (2021). Pallid Disc Oedema in a Young Patient: Clinical and Diagnostic Challenge. Neuro-Ophthalmology. 46(2). 95–98. 1 indexed citations
9.
Mullany, Sean, Ayub Qassim, Mark Hassall, et al.. (2021). Normal-tension glaucoma is associated with cognitive impairment. British Journal of Ophthalmology. 106(7). 952–956. 1 indexed citations
10.
Pye, Valerie E., Annachiara Rosa, Weston B. Struwe, et al.. (2020). A bipartite structural organization defines the SERINC family of HIV-1 restriction factors. Nature Structural & Molecular Biology. 27(1). 78–83. 41 indexed citations
11.
Qassim, Ayub, Sean Mullany, Farshad Abedi, et al.. (2020). Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes. Ophthalmology. 128(7). 993–1004. 33 indexed citations
12.
Han, Xikun, Ayub Qassim, Jiyuan An, et al.. (2019). Genome-wide association analysis of 95 549 individuals identifies novel loci and genes influencing optic disc morphology. Human Molecular Genetics. 28(21). 3680–3690. 16 indexed citations
13.
Wilkinson, Dianna E., Mark Page, Giada Mattiuzzo, et al.. (2017). Comparison of platform technologies for assaying antibody to Ebola virus. Vaccine. 35(9). 1347–1352. 18 indexed citations
14.
Page, Mark, Ruby Quartey‐Papafio, Mark W. Robinson, et al.. (2014). Complement-Mediated Virus Infectivity Neutralisation by HLA Antibodies Is Associated with Sterilising Immunity to SIV Challenge in the Macaque Model for HIV/AIDS. PLoS ONE. 9(2). e88735–e88735. 10 indexed citations
15.
Thornton, Emma, Mark Hassall, Frances Corrigan, & Robert Vink. (2014). The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model. Parkinsonism & Related Disorders. 20(5). 508–513. 24 indexed citations
16.
Hassall, Mark, Mark Page, Mark Robinson, et al.. (2013). The production, characterisation and application of monoclonal antibodies generated by immunisation with HIV-1C clade RGP140 envelope protein. Journal of Virological Methods. 194(1-2). 89–93. 1 indexed citations
17.
Page, Mark, Richard Stebbings, Neil Berry, et al.. (2012). Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model. Retrovirology. 9(1). 56–56. 4 indexed citations
18.
Hassall, Mark, et al.. (2003). Roman Britain in 2002: II Inscriptions. Britannia. 4 indexed citations
19.
Hassall, Mark. (2000). The location of legionary fortresses as a response to changes in military strategy: the case of Roman Britain AD 43-84. UCL Discovery (University College London). 1 indexed citations
20.
Hassall, Mark, et al.. (2000). Roman Britain in 1999: II. Inscriptions. Britannia. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarzyna Skonieczna Breakdown of academic impact, for papers by Mirna Kirin Breakdown of academic impact, for papers by Benjamin Chaon Breakdown of academic impact, for papers by Debra L. Fisk Breakdown of academic impact, for papers by Steve Rabson Breakdown of academic impact, for papers by William Beggs Breakdown of academic impact, for papers by Kimberly J. Perry Breakdown of academic impact, for papers by Hiroyoshi NINOMIYA Breakdown of academic impact, for papers by Stanley J. Cevario Breakdown of academic impact, for papers by B A Noble
Rankless by CCL
2026